• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An affordable pneumococcal conjugate vaccine after 20 years.

作者信息

Madhi Shabir A, Knoll Maria Deloria

机构信息

South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit and Department of Science/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Science, Johannesburg 2013, South Africa.

Department of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Lancet Infect Dis. 2021 Jun;21(6):751-753. doi: 10.1016/S1473-3099(21)00002-5. Epub 2021 Jan 28.

DOI:10.1016/S1473-3099(21)00002-5
PMID:33516294
Abstract
摘要

相似文献

1
An affordable pneumococcal conjugate vaccine after 20 years.20年后的一种价格亲民的肺炎球菌结合疫苗。
Lancet Infect Dis. 2021 Jun;21(6):751-753. doi: 10.1016/S1473-3099(21)00002-5. Epub 2021 Jan 28.
2
Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.九价肺炎球菌结合疫苗对冈比亚肺炎和侵袭性肺炎球菌疾病的疗效：随机、双盲、安慰剂对照试验
Lancet. 2005;365(9465):1139-46. doi: 10.1016/S0140-6736(05)71876-6.
3
[Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].[两岁以下儿童侵袭性肺炎球菌感染的发病率。七价肺炎球菌结合疫苗。西班牙的情况]
An Esp Pediatr. 2002 Oct;57(4):287-9.
4
Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population.在一个未曾接种过肺炎球菌疫苗的与世隔绝的原住民群体中引入13价肺炎球菌结合疫苗。
Eur Respir J. 2016 Nov;48(5):1492-1496. doi: 10.1183/13993003.00890-2016. Epub 2016 Aug 18.
5
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines - A phase II, randomised, observer-blind study in Gambian infants.含肺炎球菌蛋白的肺炎球菌结合疫苗制剂的免疫原性，以及同时接种常规疫苗的免疫原性和反应原性 - 冈比亚婴儿的 II 期、随机、观察者盲法研究。
Vaccine. 2019 May 1;37(19):2586-2599. doi: 10.1016/j.vaccine.2019.03.033. Epub 2019 Apr 8.
6
Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.乌拉圭儿童侵袭性肺炎球菌疾病：血清型分布与结合疫苗配方的比较
Vaccine. 2003 May 16;21(17-18):2093-6. doi: 10.1016/s0264-410x(02)00806-x.
7
Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.结合型肺炎球菌疫苗对日间托儿所儿童呼吸道感染发生率及抗生素使用情况的影响。
Pediatr Infect Dis J. 2001 Oct;20(10):951-8. doi: 10.1097/00006454-200110000-00008.
8
The conjugate vaccine and invasive pneumococcal disease.结合疫苗与侵袭性肺炎球菌疾病
N Engl J Med. 2003 Aug 14;349(7):714-6; author reply 714-6. doi: 10.1056/NEJMc035363.
9
The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development.13价肺炎球菌结合疫苗及正在研发的新一代更高价肺炎球菌结合疫苗所含血清型所反映的英国成年人中当代侵袭性肺炎球菌疾病和肺炎球菌肺炎的比例。
Vaccine. 2020 Dec 3;38(51):8068-8070. doi: 10.1016/j.vaccine.2020.10.090. Epub 2020 Nov 12.
10
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.肺炎球菌结合疫苗对急性中耳炎的疗效。
N Engl J Med. 2001 Feb 8;344(6):403-9. doi: 10.1056/NEJM200102083440602.

引用本文的文献

1
Otitis media sequelae and hearing in adolescence after administration of an 11-valent conjugate pneumococcal vaccine in infancy: a prospective cohort study with long-term follow-up of the ARIVAC trial.婴幼儿期接种 11 价结合型肺炎球菌疫苗后青少年期的中耳炎后遗症和听力：ARIVAC 试验的前瞻性队列研究及长期随访
Lancet Child Adolesc Health. 2024 Sep;8(9):647-655. doi: 10.1016/S2352-4642(24)00128-7. Epub 2024 Jul 31.
2
Dynamics of invasive pneumococcal disease in infants < 2 years old following PCV7/13 implementation using two infant and a booster dose schedule: evidence for indirect protection of young infants, Israel, 2004 to 2019.PCV7/13 免疫程序实施后婴幼儿（＜2 岁）侵袭性肺炎球菌病的动态变化：对小婴儿的间接保护作用的证据，以色列，2004 年至 2019 年。
Euro Surveill. 2023 Jun;28(25). doi: 10.2807/1560-7917.ES.2023.28.25.2200765.
3
Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease.南非预防肺炎球菌疾病的婴儿国家免疫规划的成本效益分析。
Infect Dis Ther. 2023 Mar;12(3):933-950. doi: 10.1007/s40121-023-00767-4. Epub 2023 Feb 12.